key: cord-0336009-8p0649oc
authors: Baladi, Tom; Nilsson, Jesper R.; Gallud, Audrey; Celauro, Emanuele; Gasse, Cécile; Levi-Acobas, Fabienne; Sarac, Ivo; Hollenstein, Marcel; Dahlén, Anders; Esbjörner, Elin K.; Wilhelmsson, L. Marcus
title: Stealth fluorescence labeling for live microscopy imaging of mRNA delivery
date: 2020-07-02
journal: bioRxiv
DOI: 10.1101/2020.07.01.172767
sha: 8caef822f7ff945a902db3a8fd089b75aa99d9d4
doc_id: 336009
cord_uid: 8p0649oc

Methods for tracking of RNA molecules inside living cells are critical to probe their dynamics and biological functions, but also to monitor delivery of therapeutic RNA. We here describe a method for fluorescence labeling of RNAs of any length, via the enzymatic incorporation of the minimally perturbing and intrinsically fluorescent tricyclic cytosine analogue tCO. Using this approach, we demonstrate incorporation of tCO in up to 100% of all natural cytosine positions of a 1.2 kb mRNA encoding for the histone H2B fused to GFP (H2B:GFP). The resulting transcript is fully compatible with both in vitro transcription and subsequent in cell translation. Spectroscopic characterization of the in vitro transcribed mRNA, shows that the incorporation rate of tCO is on par with cytosine, facilitating efficient labeling and controlled tuning of labeling ratios for different applications. Using live cell confocal microscopy and flow cytometry, we show that the tCO-labeled mRNA is efficiently and correctly translated into H2B:GFP upon electroporation as well as lipid-mediated transfection of human Huh-7 cells; correct translation was further confirmed in cell-free systems. Importantly, the spectral properties of the tCO-modified transcripts and their translation product, in this case H2B:GFP, allow for their straightforward and simultaneous visualization in live cells.

RNA is a key molecule of life and a main active player of the central dogma of molecular biology. RNA is a crucial regulator of gene expression via for instance micro (mi)-and small interfering (si)-RNA and through its intrinsic catalytic activity, RNA plays a fundamental role in biology. It has, for these reasons, also emerged as a highly promising and versatile drug modality; RNA therapeutics have the potential to modify cellular function at the translational level, which opens up entirely new opportunities to address previously undruggable targets. 1 An increased molecular and mechanistic knowledge of the biological processes involving RNA is therefore vital for understanding diseases and to treat them. A growing body of evidence suggests that the key to unleashing the full potential of RNA-based drugs lies in understanding the processes and mechanisms of cell uptake and endosomal release. 2 Regardless of the endocytosis mechanism, 3 the delivery of a nucleic acid cargo to the cytoplasm always relies on endosomal escape, the understanding of which, despite extensive investigations, remains elusive 4,5 much due to the challenges associated with visualizing RNA released to the cytosol. In this context, tracking of endogenous and exogenous (therapeutic) RNAs inside cells, including their translocation, localization, splicing and degradation, is of great importance. Recent advances have resulted in the development of a broad spectrum of tools and probes by which RNA can be analyzed and quantified, but they generally involve heavily modified oligonucleotides with properties that are significantly different from natural ones, potentially resulting in loss of ability to be correctly recognized and processed by the enzymatic machineries of cells. Hence, the development of methods for universal, minimally perturbing and internal RNA labeling schemes that are compatible with live cell imaging and fluorescence microscopy, may become as crucial for the RNA field as the discovery and understanding of the Green Fluorescent Protein (GFP) has been for proteins. [6] [7] [8] A drawback of existing fluorescence-based technologies for studying cellular localization of RNA is that they primarily rely on highly amphiphilic and/or bulky external fluorescent constructs which could impair motility and perturb localization of the RNA 9 and its molecular interactions with proteins and membrane constituents. 10 In addition, a majority of these technologies are incompatible with live cell imaging; 11 Fluorescence In Situ Hybridization (FISH), for example, can be used to visualize and quantify ribosome-mRNA interactions with single mRNA transcript resolution, 12 but it is limited to fixed cells. Förster Resonance Energy Transfer (FRET) is another highly attractive option for obtaining information on interactions, localization and relative amount of mRNA strands. It has for instance been shown that antisense oligonucleotides (ASOs) functionalized with FRET-pairs that light up only upon interaction with a specific sequence can be used to probe for specific mRNA targets.

However, binding of multiple FRET-pair-labeled ASOs to an RNA may perturb its native function by sterically blocking protein binding sites and translation; there is also a risk that the RNA target sequence is inaccessible due to complex tertiary structures of the mRNA or bound RNA proteins, causing the light-up ASO probes to report false negatives. In addition, although this approach is in principle compatible with live cell imaging, it has so far mostly been used in fixed cells, combined with FISH, to provide highly detailed, yet only static, information. 13, 14 In the few examples where RNA dynamics has been visualized in live cells, the probes were typically covalently conjugated to a vehicle, such as a DNA nanocages, 15 or gold nanoparticle, 16 before delivery to cells. Another emerging strategy for labeling RNAs is via fusion to aptamer sequences that will bind and activate fluorescent dyes in situ, 17 but it was shown that the site of insertion of such constructs onto the RNA of interest can influence the translation efficiency and protein interactions of the latter. 18 To reduce the risk of interfering with enzymatic processes, chimeric mRNAs have also been used, carrying multiple stemloop structures in the 3'-UTR and downstream of the STOP codon, which serve as binding sites for fluorescent fusion proteins. 19, 20, 21 Whilst versatile, all these labeling strategies impact profoundly on the RNA molecular weight and there is hence a risk of perturbed motility and intracellular transport.

Additional less perturbing strategies for labeling mRNA outside of the coding region include azidofunctionalized 5′-cap analogues that can be incorporated using in vitro transcription and further "clicked" to a dye inside live cells 22 and 3'-polyA tail tags based on azido-functionalized adenosine triphosphate analogues. 23 Click-chemistry approaches have also been used to introduce fluorophores into the coding sequence of an mRNA post-transcription. 24 Despite progress in these areas, external, molecular dyes, such as the cyanines Cy3 and Cy5 remain the most common labeling choice. 25, 26 Design and implementation of smaller and uncharged fluorophores for intrinsic native-like labeling of RNAs, compatible with both transcriptional and translational machineries, will therefore represent a major step forward. A first step in this direction has been taken by Ziemniak et al., who developed fluorescent 5′-cap analogues compatible with both transcription and translation. 27 However, the resulting RNA products have not been visualized inside cells, limiting the applicability of the method.

Fluorescent nucleobase analogues (FBAs) have emerged as attractive labels for both DNA and RNA and we have led the development towards increased brightness values and tuning of wavelengths of excitation and emission to facilitate their utilization in fluorescence microscopy, something that until now has not been accomplished. [28] [29] [30] Since they are internal fluorophores (i.e. involving a modification which primarily affects the oligonucleotide's interior), they are less functionally perturbing than other probes. Furthermore, their design enables them to retain the normal basepairing and -stacking of the target nucleic acid. These native-like fluorescent labels thereby open new possibilities, not only to track the nucleic acid of interest but also to use their fluorescence read-outs to obtain detailed information regarding nucleic acid structure and behavior. We have, for example, designed and implemented the first FBA interbase FRET-pair both in DNA 31 and RNA, 32,33 enabling detailed distance and orientation monitoring over more than one turn of the duplex. Fluorescent RNA base analogues have also been used to study the rate of codon:anticodon base-pair formation during translation 34 and a few studies demonstrate their use as substrates for in vitro transcription reactions, demonstrating T7 RNA polymerase mediated incorporation the fluorescent tricyclic cytosine analogue tCTP into ca. 800 nucleotide (nt) non-coding RNA strands 35 or the production of short transcripts incorporating fluorescent isomorphic guanine 36, 37 and uridine 38,39 analogues,

respectively. Yet again, none of these studies have explored if it is feasible to probe the labeled RNAs by their fluorescence in a live cell context.

In this study, we have developed a method to incorporate fluorescent base analogue internal labels at desired ratios into a 1.2 kb long coding mRNA and demonstrated the functionality of the resulting fluorescent transcript both in vitro and by live cell confocal microscopy imaging in a drug delivery context. Our method, that presumably is applicable to most mRNAs, allows for efficient in vitro transcription and, remarkably, an effective in-cell translation of full-length mRNAs internally labeled with the fluorescent tricyclic cytosine tC O at all cytosine positions. The absorption of tC O is centered at 369 nm ( 369 = 9370 M -1 cm -1 ) and it fluoresces intensely in single-stranded (ss) RNA (< > = 0.24), with maximum emission at 457 nm. 32 We demonstrate that the tC O -mRNA is readily imageable inside live cells using the standard 405 nm laser line of a confocal microscope for excitation and, moreover, that we can simultaneously follow the emergence of the transcript's protein product -histone protein H2B fused to GFP (H2B:GFP), which localizes to the nucleus ( Figure 1 ). We also present an alternative enzymatic labeling strategy for RNAs of any length in which we demonstrate the conjugation of tC O to the end of RNA sequences. Since the tC O label is compatible with biological processes that RNA participates in, it holds a great potential to become a powerful imaging tool in live cell microscopy. Specifically, we envision this approach to facilitate drug delivery studies, enabling effective visualization of cellular uptake, endosomal release, exosomal loading and trafficking of mRNA.

Synthesis of the tricyclic cytosine analog (tC O ) triphosphate Since the Yoshikawa 40 and Ludwig-Eckstein 41 conditions were published in 1969 and 1989, respectively, a plethora of alternatives have been developed for the triphosphorylation of nucleosides. [42] [43] [44] [45] The abundance of literature on this matter well illustrates the "hit-and-miss" aspect of triphosphate synthesis. Both the triphosphorylation process and the laborious purification of the very polar final products are liable for the typically low synthesis yields. To improve the reaction yield and facilitate purification of the final product during the synthesis of modified RNA triphosphates, we opted for a synthetic scheme (Fig. 1 ) starting from a solid-supported ribonucleoside; this approach has surprisingly only been reported for unmodified nucleobases with 2′-OMe protection. 46, 47 The final reaction, relying on well-established phosphoramidite chemistry, involves the use of CycloSal-phosphoramidite 5 and bis(tetrabutylammonium) dihydrogen pyrophosphate 6 ( Fig. 1) , which are prepared from commercially available 5-chlorosalicylic acid and pyrophosphoric acid. This method was developed by Meier et al. 48 to achieve efficient 5′-triphosphorylation of short solid support-bound DNA and RNA oligonucleotides in moderate to good yields. Interestingly, it was originally used for solution-based synthesis of unmodified ribonucleosides and deoxyribonucleosides, 49 but has progressively been combined with solid supports to facilitate purification of the products. 50 In our hands, both Krupp's 46 and Meier's 48 solid-phase triphosphorylation methods yielded the product, though Meier's gave a higher yield. To the best of our knowledge, the CycloSal-phosphoramidite method on solid support described herein has never been applied to a single ribonucleoside before, let alone to produce a modified base analogue.

Briefly, long-chain alkylamino controlled-porosity glass (CPG) support was functionalized with a succinyl moiety. Protected ribonucleoside 1 was synthesized according to a method by Füchtbauer et al. 32 and attached to the succinylated support via ester bond formation (Fig. 1) . The resulting ribonucleoside 4 on solid support could be stored in the dark at room temperature, with no degradation observed over three months. Interestingly, intermediate 4 could also be synthesized via succinylation of ribonucleoside 1 in solution followed by coupling with the amino support 2.

Subsequently, triphosphorylation of ribonucleoside 4 was performed using the CycloSal method.

After triphosphorylation, support-bound triphosphate was deacetylated and cleaved from the CPG support using ammonium hydroxide/methylamine (AMA) for two hours at room temperature.

Subsequent reverse phase or ion-exchange chromatography allowed the desired triphosphate 7 in a triphosphorylation yield of 60% and with a high UV purity of 99%. Importantly, up to 85% of the unreacted nucleoside 1 could conveniently be recovered by precipitation from the first reaction crude, compensating for the low loading achieved. Considering this, our triphosphorylation method gives an overall yield of up to 30%, which is higher than most solution-based alternatives.

The tC O triphosphate (tC O TP) was used to produce fluorescently labeled RNA via two different enzymatic pathways. First, we performed tail-labeling of short RNA oligonucleotides using the terminal deoxynucleotidyl transferase enzyme (TdT, Fig. 1 , blue arrow). This template-independent DNA polymerase appends both natural and modified nucleotides at the 3'-end of single-stranded oligonucleotides but, unlike most DNA polymerases, TdT displays a characteristic low discrimination for deoxyribo-over ribonucleoside triphosphates, enabling modification also of RNA. 51, 52 The TdTmediated tail-labeling of a 17-mer ssRNA (TdT1, see Supplementary Table 1 for sequence) resulted in successful addition of multiple tC O s (from one to more than 25) and with near full conversion of the RNA primer (Fig. 2b) . The TdT usually displays no strict metal cation preference, 51 which was confirmed also in our case, with equally effective addition of tC O s with Co(II), Mg(II), or Mn(II) as enzymatic co-factor. Thus, even though RNA nucleotides have been reported to be relatively poor substrates for TdT, 53, 54 tC O TP appears to be well tolerated by this enzyme. We next demonstrated that it is possible to use this approach to tail-label also longer RNA sequences, enzymatically adding tC O s to a 50 nt ssRNA (TdT2, Supplementary Table 1 ). The labeling was effective also in this case resulting in near full conversion of the primer, but led to a significantly higher degree of product uniformity; the main products contained one or two tC O incorporations ( Supplementary Fig. 1 ). The fluorescence originating from a tC O tail-labeled oligonucleotide was clearly observable by naked eye upon UV irradiation (Fig. 2c) . This result shows that the tricyclic tC O analogue can be effectively read by the TdT enzyme and thereby incorporated into RNA of any length providing site-specific discrimination factor against the formation of mismatched tC-A base pairs. 35 We therefore evaluated the propensity of tC O TP to be misinserted opposite to template deoxyadenosines using the templates DNA3 and DNA4 (Supplementary Table 1 

In order to verify the functionality of the tC O -labeled mRNA transcripts we investigated translation of in vitro transcribed Calmodulin-3 mRNA in cell-free conditions using bacterial lysates (Fig. 1, yellow arrows). The labeled mRNA was produced using a commercial Calmodulin-3 DNA template plasmid using the same tC O TP/CTP ratios as for the H2B:GFP encoding mRNA (0 to 100% of tC O TP). After RNA purification and cell-free translation, we confirmed the presence of Calmodulin-3 by Coomassie staining (Fig. 5a ) as well as Western Blot (Fig. 5b) . Satisfactorily, we observed stable protein expression levels when increasing the tC O content of the transcripts, ranging from 80%-137% of the non-labeled control (Figure 5c ). This result suggests that tC O , unlike other sugar-57 or base-modified 64 nucleotide analogues, does not impair ribosomal processing in cell-free systems. 

We used electroporation to introduce the in vitro-transcribed tC O -labeled mRNA transcripts into human neuroblastoma SH-SY5Y cells (Figure 1 , second green arrow). Taking advantage of the fact that the mRNA encodes for a fluorescent fusion protein with nuclear localization (H2B:GFP), the translation could conveniently be detected via the product's fluorescence (Fig. 6 ). To improve stability and reduce cytosolic degradation, the mRNA was capped with a 5′-Cap 0 analogue and 3'protected by poly-adenylation (by ca. 300 nt). We showed by live cell confocal fluorescence microscopy and flow cytometry analysis that nuclear GFP fluorescence could be detected in 32%, 25%, 18%, and 12% of the cells 24 hours post the electroporation of mRNA containing 25%, 50%, 75% and 100% of tC O (Fig. 5a and Supplementary Fig. 8a ). In comparison, the transfection efficiency with unmodified mRNA was 46%. This provides the first observation that an FBA-modified RNA transcript can be accurately and efficiently translated by human ribosomal machineries, resulting in a correctly localized and folded protein product. Using flow cytometry, we quantified the levels of H2B:GFP fluorescence in the cells (Fig. 5b) , observing a decrease in mean cellular H2B:GFP fluorescence intensity upon increasing the percentage of tC O in the transcript (approximately one order of magnitude difference between 0 and 100% of tC O (Fig. 5a and 5f) ). This suggests that at least under these conditions, mRNA translation, as opposed to transcription, is somewhat impeded by the tC O modification, especially at the highest degree of incorporation. Importantly, we found no evidence of mRNA-induced cell toxicity up to 24 hours post-electroporation ( Supplementary Fig. 8g ). Of significant note is that the mean fluorescence intensity of translated protein in cell cultures electroporated with a commercial enhanced GFP-encoding mRNA tagged with Cy5 via conjugation to UTPs (ca. 25% of all U positions of this mRNA are labeled) was only 17% of that in cell cultures electroporated with the corresponding non-labeled sequence (Fig. 5f ). This is comparable to the effect of a 50%-75% labeled tC O transcript, which suggests that the external Cy5 modification indeed affects the ribosome translation capability more than tC O does. We continued to monitor the mRNAtreated cells up to 72 h post-electroporation, and noted a continuous decrease in the GFP fluorescence signal over time with a 56%±5% loss for the unlabeled mRNA against 47%±8% loss for the tC O -labeled mRNAs when compared to the 24 h time point (Fig. 6a) . This is likely a combined effect of mRNA degradation and cell division (the doubling time of SH-SY5Y cells under our experimental conditions is approximately 24 hours not appearing to be significantly impacted by tC O ).

It is evident from the images in Fig. 6a and 6e that neither the fluorescent tC O -labeled mRNA nor the Cy5-labeled mRNA can be detected inside cells after electroporation due to their low/diffused cytoplasmic concentration, as expected and in agreement with other reports. 65 We therefore investigated the delivery of the H2B:GFP transcripts using a chemical transfection reagent (lipofectamine), which is also more relevant from a drug delivery perspective. This also resulted in the successful production of H2B:GFP ( Fig. 6c and Supplementary Fig. 8b and 8d) , demonstrating that the modified mRNA can undergo endosomal escape. The delivery efficiency was between 3.8%-4.6% of H2B:GFP-positive cells for the tC O -labeled transcripts compared to 12%-32% using electroporation.

This reflects the relatively poor transfectability of SH-SY5Y cells compared to many other cell lines 66 rather than the transfectability of tC O -labeled constructs, as further supported by the finding that cultures transfected with non-modified mRNA displayed a virtually identical response (4.5% of cells expressing H2B:GFP). An interesting point is that the H2B:GFP fluorescence increases gradually with time between 24 h and 72 h (Fig. 6c) , which is a contrasting behavior compared to electroporated cells (Fig. 6a) . This likely reflects the fact that the lipofectamine-mRNA complexes are continuously internalized and, potentially, that endocytosed complexes progressively release more transcripts with time, counteracting the degradation that mRNA experiences in the cytosol. The most noticeable finding of this experiment is that lipofectamine-delivered tC O -labeled mRNAs promote very similar H2B:GFP translation compared to the corresponding non-labeled mRNA, as indicated by the fluorescence levels in Fig. 6f . The Cy5-tagged mRNA, on the other hand, results in an average fluorescence level that is 80% lower than that of its corresponding non-labeled transcript. This suggests that tC O does not impair the ability of mRNA to be processed by ribosomes upon chemical transfection, possibly because of an absence of charge and reduced steric hindrance, whereas Cy5, currently the most common commercial fluorophore for mRNA labeling, considerably impacts translation. It could also be an effect of the Cy5-labeling, as a result of its amphiphilic character, interacts differently with cellular membranes and/or delivery vehicle constituents and consequently impedes the transport of the Cy5-labeled mRNA to the location of translation.

Importantly, the complexation of the tC O -labeled mRNA with lipofectamine enabled its direct visualization inside cells using live cell confocal microscopy (Fig. 6c, red puncta) . This represents the first observation of FBA-labeled nucleic acids inside live cells. We also showed that it is possible to We envision that our straightforward approach for introducing non-perturbing fluorescent labels into RNA will be an excellent addition to existing imaging tools, applicable for elucidating trafficking mechanisms such as endosomal escape and exosome formation, both of which are of fundamental importance for pharmaceutical development. In principle, these methodologies can also be adapted to other base analogues (to access for instance different spectral properties), provided that the corresponding FBA triphosphate is tolerated by the enzymatic machinery as straightforwardly as the herein investigated tC O TP. Applying both our TdT end-labeling and T7 transcription strategies also holds significant combined potential as it would enable selective and site-specific incorporation of dual labels to allow for e.g. FRET applications. We are convinced that the development reported here will benefit pharmaceutical industry, clinical laboratories, and academic partners aiming at furthering their understanding of uptake and endosomal escape mechanisms and allow them to take vital steps towards new and improved delivery strategies for next-generation nucleic acid-based drugs.

Commercially available reagents were used without further purification. The following reagents used for the triphosphorylation were bought from Sigma-Aldrich: DCA deblock for ÄKTA, CAP A for ÄKTA, CAP B1 and B2 for ÄKTA, BTT Activator. 1 H (500 MHz) and 13 C (126 MHz) NMR spectra were recorded at 300 K on a Bruker 500 MHz system equipped with a CryoProbe. 31 P (202 MHz) NMR spectra were recorded at 300 K on a Bruker 500 MHz system. All shifts are recorded in ppm relative to the deuterated solvent (DMSO-d6, CDCl3 or D2O).

Compound was prepared according to the literature. 32 Succinylated CPG could thereafter be kept at room temperature for several months. ((2R,3S,4R,5R)-3,4-dihydroxy-5-(2-oxo-2,10-dihydro-3H-benzo[b]pyrimido[4,5-e][1,4] oxazin-3yl)tetrahydrofuran-2-yl)methyl triphosphate 7: Reaction was performed in a 5 mL syringe with PTFE filter loaded with 4 (800 mg, 0.016 mmol) under an argon atmosphere and shaking.

Steps were performed as following: Fitting of fluorescence lifetimes. The intensity decays were fitted with IRF re-convolution to the multiexponential model shown in equation S3.

The least-square re-convolution fitting procedure was carried out using the DecayFit software 

Assuming that the product RNA is uniform in size (1247 nucleotides), its base composition (A: 408, U:

272, G: 307, C: 260) allows for equations S10 -S13.

[ (S14)

Using the volume of the cell-free reaction (50 µL) and resulting product solution (100 µL), equation S15 was applied to calculate the 0 incorporation yield ( 0 ).

[ 0 ] × 100 µL

[ 0 ] 0 × 50 µL (S15)

Consonantly, the RNA yield ( ) was calculated according to equation S16. 

The original coding sequence for H2B:GFP was taken from pCS2-H2B:GFP plasmid (Addgene, Plasmid #53744, Supplementary Fig. 6 ), manually codon-optimized to minimize the occurrence of poly-Cn stretches (n<3), in silico-assembled with an additional T7 promoter and other desired features (Shine-Dalgarno/Kozak consensus sequences for enhancement of translation and a 3xStop, respectively at the 5′ and 3′ of the coding sequence itself, plus the needed HindIII/SnaBI restriction sites, to generate the ligation-prone sticky ends) and ordered from Twist Bioscience as a synthetic gene block (Supplementary Fig. 6 ). The obtained sequence was then PCR-amplified, using a Phusion with incubation extended to 1 hour) and a Cap 0 analog (using a Vaccinia capping system, NEB protocol #M2080), following the recommended procedures. This was necessary to increase, respectively, affinity for the cellular translation machinery and resistance to endogenous nucleases. 

The data that support the plots within this paper and the findings of this study are available from the corresponding author upon reasonable request.

Calmodulin-like 3 protein is provided as a positive control plasmid (pEXP5-NT/CALML3) in the kit itself; this DNA vector contains a T7 polymerase promoter and a 6xHis tag, hence it was first in vitro-transcribed in presence of the desired concentrations of tC O TP (vide supra). The obtained RNAs, once purified, were used as templates for the cell-free translation reaction according to the manufacturer

For Coomassie staining, the gel was then washed three times in boiling water, to remove excess of SDS, on a benchtop shaker; a 1x Coomassie non-toxic staining solution was added to the gel and microwaved until initial boiling. 79 Gel was finally washed after the appropriate incubation time, to remove excess of background noise, in distilled water and imaged using a ChemiDoc Touch. For Western Blot, the gels were blotted onto PVDF LF ethanol-activated membranes

RNA-Targeted Therapeutics

Overcoming cellular barriers for RNA therapeutics

Regulated portals of entry into the cell

Cellular uptake and trafficking of antisense oligonucleotides

Overcoming Endosomal Entrapment in Drug Delivery

Extraction, Purification and Properties of Aequorin, a Bioluminescent Protein from the Luminous Hydromedusan

Fluorescent Analogues of Biomolecular Building Blocks: Design and Applications Ch

Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown

Characterization of the interactions of chemically-modified therapeutic nucleic acids with plasma proteins using a fluorescence polarization assay

Choose Your Label Wisely: Water-Soluble Fluorophores Often Interact with Lipid Bilayers

Biochemical Methods To Image and Analyze RNA Localization: From One to Many

A Fluorescence in Situ Hybridization Method To Quantify mRNA Translation by Visualizing Ribosome-mRNA Interactions in Single Cells

mRNA detection in budding yeast with single fluorophores

Quantitative mRNA Imaging with Dual Channel qFIT Probes to Monitor Distribution and Degree of Hybridization

Fluorescence Resonance Energy Transfer-Based DNA Tetrahedron Nanotweezer for Highly Reliable Detection of Tumor-Related mRNA in Living Cells

A novel dual energy transfer probe for intracellular mRNA detection with high robustness and specificity

Visualizing RNA dynamics in live cells with bright and stable fluorescent RNAs

RNA imaging in living cells -methods and applications

Localization of ASH1 mRNA Particles in Living Yeast

Dynamics of Translation of Single mRNA Molecules In Vivo

Real-Time Imaging of Translation on Single mRNA Transcripts in Live Cells

Azido-Functionalized 5′ Cap Analogues for the Preparation of Translationally Active mRNAs Suitable for Fluorescent Labeling in Living Cells

Multiple covalent fluorescence labeling of eukaryotic mRNA at the poly(A) tail enhances translation and can be performed in living cells

Chemoenzymatic Preparation of Functional Click-Labeled Messenger RNA

Heterocyclic Polymethine Dyes: Synthesis, Properties and Applications

A Metabolic Engineering Approach to Incorporate Modified Pyrimidine Nucleosides into Cellular RNA

Synthesis and evaluation of fluorescent cap analogues for mRNA labelling

Fluorescent nucleobases as tools for studying DNA and RNA

Fluorescent Analogs of Biomolecular Building Blocks: Design, Properties, and Applications

Fluorescent nucleic acid base analogues

Nucleic Acid Base Analog FRET-Pair Facilitating Detailed Structural Measurements in Nucleic Acid Containing Systems

Fluorescent RNA cytosine analogue -an internal probe for detailed structure and dynamics investigations

Interbase FRET in RNA: from A to Z

Stringent Nucleotide Recognition by the Ribosome at the Middle Codon Position

Incorporation of the Fluorescent Ribonucleotide Analogue tCTP by T7 RNA Polymerase

Isomorphic Emissive GTP Surrogate Facilitates Initiation and Elongation of in Vitro Transcription Reactions

Polymerase-Mediated Site-Specific Incorporation of a Synthetic Fluorescent Isomorphic G Surrogate into RNA

A Microenvironment-Sensitive Fluorescent Pyrimidine Ribonucleoside Analogue: Synthesis, Enzymatic Incorporation, and Fluorescence Detection of a DNA Abasic Site

Synthesis and Enzymatic Incorporation of a Responsive Ribonucleoside Probe That Enables Quantitative Detection of Metallo-Base Pairs

Studies of Phosphorylation. III. Selective Phosphorylation of Unprotected Nucleosides

Rapid and efficient synthesis of nucleoside 5'-0-(1-thiotriphosphates), 5'-triphosphates and 2',3'-cyclophosphorothioates using 2-chloro-4H-1,3,2-benzodioxaphosphorin-4-one

Recent Trends in Nucleotide Synthesis

Syntheses of Nucleoside Triphosphates

Chemical methods for the modification of RNA

Enzymatic Synthesis of Base-Functionalized Nucleic Acids for Sensing, Crosslinking, and Modulation of Protein-DNA Binding and Transcription

Novel solid phase synthesis of 2'-o-methylribonucleoside 5'-triphosphates and their α-thio analogues

A facile solid phase synthesis of 2′-and 3′-aminonucleoside triphosphates

Efficient Automated Solid-Phase Synthesis of DNA and RNA 5′-Triphosphates

Synthesis of Nucleoside Di-and Triphosphates and Dinucleoside Polyphosphates with cycloSal-Nucleotides

Solid-Phase Synthesis of (Poly)phosphorylated Nucleosides and Conjugates

Terminal Deoxynucleotidyl Transferase in the Synthesis and Modification of Nucleic Acids

Terminal deoxynucleotidyl transferase: The story of a misguided DNA polymerase

One-step enzymatic modification of RNA 3' termini using polymerase θ

Site-specific terminal and internal labeling of RNA by poly(A) polymerase tailing and copper-catalyzed or copper-free strainpromoted click chemistry

Fluorescent Pyrimidine Ribonucleotide: Synthesis, Enzymatic Incorporation, and Utilization

T7 RNA Polymerase Transcription with 5-Position Modified UTP Derivatives

Translation of 2'-modified mRNA in vitro and in vivo

The synthesis and application of a diazirinemodified uridine analogue for investigating RNA-protein interactions

Site-specific enzymatic introduction of a norbornene modified unnatural base into RNA and application in post-transcriptional labeling

Structural Basis for Substrate Selection by T7 RNA Polymerase

Principles of Fluorescence Spectroscopy

High Density Labeling of Polymerase Chain Reaction Products with the Fluorescent Base Analogue tCo

Ambivalent Incorporation of the Fluorescent Cytosine Analogues tC and tCo by Human DNA Polymerase α and Klenow Fragment

The presence of modified nucleosides in extracellular fluids leads to the specific incorporation of 5-chlorocytidine into RNA and modulates the transcription and translation

Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown

Efficiency of gene transfection reagents in NG108-15, SH-SY5Y and CHO-K1 cell lines

Bis-cycloSal-d4T-monophosphates: Drugs That Deliver Two Molecules of Bioactive Nucleotides

Evolution of functional nucleic acids in the presence of nonheritable backbone heterogeneity

Transcription yield of fully 2′-modified RNA can be increased by the addition of thermostabilizing mutations to T7 RNA polymerase mutants

Development of RNA Aptamers Targeting Ebola Virus VP35

WebLogo: a sequence logo generator

T7 RNA polymerase studied by force measurements varying cofactor concentration

Regeneration of total RNA purification silica-based columns

Bleach gel: a simple agarose gel for analyzing RNA quality

R: A language and environment for statistical computing

Fiji: an open-source platform for biological-image analysis

Staining of proteins in gels with Coomassie G-250 without organic solvent and acetic acid

Audrey Gallud

Xenome Team, 5 rue Henri Desbruères Genopole Campus 1

designed and supervised the study. T.B. and I.S. designed and performed the synthesis of the modified triphosphate. E.C. and C.G. did the in vitro transcription assays and E.C. the in vitro translation assays. C.G. performed the reverse transcriptions and sequencing. F.L.-A. did the TdT labeling assays

A.D. is an employee of AstraZeneca and may hold shares in the company.

L. Marcus Wilhelmsson email address: marcus.wilhelmsson@chalmers.se Elin K. Esbjörner email address: eline@chalmers.se